Allogeneic hematopoietic cell transplantation (alloHCT) for patients over 65 years old is not associated with worse symptoms/function than younger patients - a Center for International Blood and Marrow Transplant Research (CIBMTR) study Shaw, B., Brazauskas, R., Burns, L. J., Mattila, D., Musseter, A., Chen, M., Vasu, S., Pidala, J., Muffly, L., Uberti, J., Tamari, R., Tamari, R., Leckrone, E., Myers, J., Mau, L., Rizzo, J., Saber, W., Horowitz, M. M., Lee, S. J., Flynn, K. E. SPRINGER. 2020: S29

View details for Web of Science ID 000584632700070